Pavia, Italy

Lalo Magni

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Dipartimento Di Ingegneria Civile E Architettura Dell'università Degli Studi Di Pavia, Universitá Degli Studi Di Padova. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lalo Magni. Retrieved from https://idiyas.com/inventor/lalo-magni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lalo Magni: Innovator in Diabetes Management

Introduction

Lalo Magni is a notable inventor based in Pavia, Italy, recognized for his contributions to diabetes management through innovative methods. His work focuses on improving the delivery of insulin to diabetic patients, enhancing their quality of life.

Latest Patents

Lalo Magni holds a patent for a "Method for controlling the delivery of insulin and the related system." This method controls insulin delivery in diabetic patients based on data representative of a meal that the patient will consume. The system utilizes a reference insulin value derived from conventional therapy and feedback data regarding the patient's glycemic level. This innovative approach aims to provide a more accurate and responsive insulin delivery system.

Career Highlights

Throughout his career, Lalo Magni has worked with esteemed institutions such as the Department of Civil Engineering and Architecture at the University of Pavia and the University of Padua. His academic and professional experiences have significantly contributed to his expertise in the field of diabetes management.

Collaborations

Lalo has collaborated with notable colleagues, including Paola Soru and Chiara Toffanin, who have contributed to his research and development efforts in the field.

Conclusion

Lalo Magni's innovative approach to insulin delivery represents a significant advancement in diabetes care. His patent and collaborative efforts highlight his commitment to improving patient outcomes through technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…